OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20528232

Download in:

View as

General Info

PMID
20528232